These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9718603)

  • 21. HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish?
    Cohen MS
    Sex Transm Dis; 2008 Dec; 35(12):979-80. PubMed ID: 18955917
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of antiretroviral drugs to prevent sexual transmission of HIV.
    Cohen MS; Hosseinipour M; Kashuba A; Butera S
    Curr Clin Top Infect Dis; 2002; 22():214-51. PubMed ID: 12520656
    [No Abstract]   [Full Text] [Related]  

  • 23. [Early treatment of sexual exposure to human immunodeficiency virus].
    Derancourt C; Drobacheff C; Verraes S; Beguinot I; Bernard P
    Ann Dermatol Venereol; 2000 Jan; 127(1):122-4. PubMed ID: 10717578
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV postexposure prophylaxis after sexual assault.
    Stevens L; Brown MA
    Nurse Pract Forum; 2001 Dec; 12(4):192-8. PubMed ID: 11889687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study follows PEP for sexual exposures.
    AIDS Alert; 1998 Sep; 13(9):106-7. PubMed ID: 11365790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accomplishments in HIV prevention science: implications for stemming the epidemic.
    Valdiserri RO; Ogden LL; McCray E
    Nat Med; 2003 Jul; 9(7):881-6. PubMed ID: 12835709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postexposure HIV prophylaxis after sexual assault.
    Huffman GB
    Am Fam Physician; 1999 Nov; 60(7):2123, 2127. PubMed ID: 10569512
    [No Abstract]   [Full Text] [Related]  

  • 28. Durability of clinical responses to anti-HIV therapies.
    Laurence J
    AIDS Read; 2008 Mar; 18(3):120-1. PubMed ID: 18398977
    [No Abstract]   [Full Text] [Related]  

  • 29. Advocating for rectal microbicides.
    AIDS Read; 2008 May; 18(5):235. PubMed ID: 18589876
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update. HIV-positive man convicted of exposing women to HIV.
    AIDS Policy Law; 2006 Oct; 21(20):8. PubMed ID: 17165194
    [No Abstract]   [Full Text] [Related]  

  • 33. Postexposure prophylaxis for HIV infection.
    Nwokolo NC; Hawkins DA
    AIDS Read; 2001 Aug; 11(8):402-12. PubMed ID: 11570266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV optimism: fact or fiction?
    Elford J; Bolding G; Sherr L
    Focus; 2001 Jul; 16(8):1-4. PubMed ID: 11548464
    [No Abstract]   [Full Text] [Related]  

  • 35. CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention.
    AIDS Policy Law; 1997 Jun; 12(12):4. PubMed ID: 11364408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV prevention in the era of new treatments.
    Demmer C
    Health Promot Pract; 2003 Oct; 4(4):449-56. PubMed ID: 14611030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prophylaxis after occupational exposure to HIV].
    Torten D; Bentwich Z
    Harefuah; 2000 Apr; 138(8):671-7. PubMed ID: 10883211
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of highly sensitive assays for the evaluation of post-exposure HIV prophylaxis.
    Schockmel GA; Balavoine JF; Yerly S; Perrin L
    AIDS; 1998 Sep; 12(13):1726-7. PubMed ID: 9764799
    [No Abstract]   [Full Text] [Related]  

  • 39. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
    Kahn JO; Martin JN; Roland ME; Bamberger JD; Chesney M; Chambers D; Franses K; Coates TJ; Katz MH
    J Infect Dis; 2001 Mar; 183(5):707-14. PubMed ID: 11181146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylactic antiretroviral therapy after sexual exposure to HIV: 93 cases].
    Timsit FJ; Maillard A; Spindler E; Taquin Y; Deniaud F; Ferchal F; Morel P; Janier M
    Ann Dermatol Venereol; 2002; 129(6-7):866-9. PubMed ID: 12218913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.